Cargando…

Identification of potential oncogenes in triple-negative breast cancer based on bioinformatics analyses

Triple-negative breast cancer (TNBC) is a subtype with high rates of metastasis, poor prognosis and limited therapeutic options. The present study aimed to identify the potential pivotal genes for prognosis and treatment in TNBC. A total of two microarray expression datasets, GSE38959 and GSE65212,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Xiao, Zhang, Zheng, Luo, Ruihan, Peng, Rui, Sun, Yan, Wang, Jia, Chen, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967975/ https://www.ncbi.nlm.nih.gov/pubmed/33747220 http://dx.doi.org/10.3892/ol.2021.12624

Ejemplares similares

Identification of ribosomal protein family in triple-negative breast cancer by bioinformatics analysis
por: Lin, Ziyue, et al.
Publicado: (2021)

Bioinformatics analysis of key genes in triple negative breast cancer and validation of oncogene PLK1
por: Ren, Yi, et al.
Publicado: (2020)

Identification of potential core genes in triple negative breast cancer using bioinformatics analysis
por: Li, Man-Xiu, et al.
Publicado: (2018)

Identification of Key Genes and Pathways in Triple-Negative Breast Cancer by Integrated Bioinformatics Analysis
por: Dong, Pengzhi, et al.
Publicado: (2018)

ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer
por: Fang, Wentong, et al.
Publicado: (2021)

Integrated bioinformatic analysis of potential biomarkers of poor prognosis in triple-negative breast cancer
por: Bissanum, Rassanee, et al.
Publicado: (2022)

Identification of Key Prognostic Genes of Triple Negative Breast Cancer by LASSO-Based Machine Learning and Bioinformatics Analysis
por: Chen, De-Lun, et al.
Publicado: (2022)

SHP2 Potentiates the Oncogenic Activity of β-Catenin to Promote Triple-Negative Breast Cancer
por: Martin, Elisha, et al.
Publicado: (2021)

Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer
por: Sánchez-Muñoz, Alfonso, et al.
Publicado: (2010)

Identification of Potential Key Genes Associated With the Pathogenesis, Metastasis, and Prognosis of Triple-Negative Breast Cancer on the Basis of Integrated Bioinformatics Analysis
por: Zhao, Bin, et al.
Publicado: (2020)

Identification and validation of a combined hypoxia and immune index for triple‐negative breast cancer
por: Zheng, Shaoquan, et al.
Publicado: (2020)

Identification of gut metabolites associated with Parkinson’s disease using bioinformatic analyses
por: Yan, Jun, et al.
Publicado: (2022)

Super-enhancer acquisition drives oncogene expression in triple negative breast cancer
por: Raisner, Ryan, et al.
Publicado: (2020)

Multiomics analysis reveals CT83 is the most specific gene for triple negative breast cancer and its hypomethylation is oncogenic in breast cancer
por: Chen, Chen, et al.
Publicado: (2021)

The oncogenic miR-429 promotes triple-negative breast cancer progression by degrading DLC1
por: Li, Yao, et al.
Publicado: (2023)

Bioinformatics identification of dysregulated microRNAs in triple negative breast cancer based on microRNA expression profiling
por: Chen, Junqing, et al.
Publicado: (2018)

Identification by Comprehensive Bioinformatics Analysis of KIF15 as a Candidate Risk Gene for Triple-Negative Breast Cancer
por: Sheng, Jiayu, et al.
Publicado: (2020)

An integrated bioinformatics analysis to dissect kinase dependency in triple negative breast cancer
por: Ryall, Karen A, et al.
Publicado: (2015)

MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer
por: Li, Qun, et al.
Publicado: (2017)

Molecular analyses of triple-negative breast cancer in the young and elderly
por: Aine, Mattias, et al.
Publicado: (2021)

Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer
por: Zurlo, Giada, et al.
Publicado: (2019)

Identification of the potential oncogenes in glioblastoma based on bioinformatic analysis and elucidation of the underlying mechanisms
por: Zhang, Yong, et al.
Publicado: (2018)

High Expression of RAI14 in Triple-Negative Breast Cancer Participates in Immune Recruitment and Implies Poor Prognosis Through Bioinformatics Analyses
por: Cui, Ranliang, et al.
Publicado: (2022)

Identification of Long Noncoding RNAs as Predictors of Survival in Triple-Negative Breast Cancer Based on Network Analysis
por: Li, Xiao-Xiao, et al.
Publicado: (2020)

Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
por: Jézéquel, Pascal, et al.
Publicado: (2019)

Identification of a potential gene target for osteoarthritis based on bioinformatics analyses
por: Duan, Zhi-xi, et al.
Publicado: (2020)

Bioinformatics combined with quantitative proteomics analyses and identification of potential biomarkers in cholangiocarcinoma
por: Da, Zijian, et al.
Publicado: (2020)

Molecular mechanism of oroxyli semen against triple-negative breast cancer verified by bioinformatics and in vitro experiments
por: Chen, Lulu, et al.
Publicado: (2023)

The Chk1 inhibitor MK-8776 increases the radiosensitivity of human triple-negative breast cancer by inhibiting autophagy
por: Zhou, Zhi-rui, et al.
Publicado: (2017)

rs11046147 mutation in the promoter region of lactate dehydrogenase‐B as a potential predictor of prognosis in triple‐negative breast cancer
por: Liu, Jia, et al.
Publicado: (2020)

Correction to: Molecular analyses of triple-negative breast cancer in the young and elderly
por: Aine, Mattias, et al.
Publicado: (2021)

Treatment for Triple-Negative Breast Cancer: An Umbrella Review of Meta-Analyses
por: Yin, Jianyun, et al.
Publicado: (2022)

Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets
por: Lv, Yan, et al.
Publicado: (2021)

Sesquiterpenoids from Inula britannica and Their Potential Effects against Triple-Negative Breast Cancer Cells
por: Qi, Ruo-Yu, et al.
Publicado: (2022)

Targeting oncogenic vulnerabilities in triple negative breast cancer: biological bases and ongoing clinical studies
por: Ocana, Alberto, et al.
Publicado: (2017)

Mutant p53 dictates the oncogenic activity of c-Abl in triple-negative breast cancers
por: Morrison, Chevaun D, et al.
Publicado: (2017)

Mesenchymal Cells Support the Oncogenicity and Therapeutic Response of the Hedgehog Pathway in Triple-Negative Breast Cancer
por: Reyes-Ramos, Ana M., et al.
Publicado: (2019)

The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer
por: Wang, Wei, et al.
Publicado: (2023)

Identification and validation of a five-gene prognostic signature based on bioinformatics analyses in breast cancer
por: Du, Xin-jie, et al.
Publicado: (2023)

Identification of key genes as potential biomarkers for triple-negative breast cancer using integrating genomics analysis
por: Zhong, Guansheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h6grd7q1ppgpafftejfu76mu3t